Medical Device Industry News

  • Serious Recall Involves Incompatible Defibrillator Electrodes

    There is apparently a dangerous connector incompatibility problem involving a Leonhard Lang defibrillation electrode. Joyce Laird

  • Abbott, St. Jude Selling Vascular Closure Portfolio for $1.12 Billion

    The sale to Terumo is subject to Abbott Labs completing its $25 billion purchase of St. Jude Medical. Chris Newmarker Abbott has yet to complete its acquisition of St. Jude Medical, but the two companies are already making deals to shed off businesses that are not core to the giant medical device company they are creating.

  • Medtronic Scores Approval for MRI-Compatible Devices

    A new FDA approval allows patients with a wide range of Medtronic cardiac rhythm and heart failure devices to undergo MRI scans anywhere in their body. Joyce Laird

  • Datwyler Building $102 Million Plant in Delaware

    The new facility will make high-quality elastomer components for injectable drug delivery systems. Chris Newmarker

  • Titan Takes on Intuitive Surgical

    Titan Medical’s Sport surgical robotic system closely shadows Intuitive Surgical's DaVinci—but at a much lower cost. Joyce Laird

  • Hoya Spending $476 Million on Lens Maker

    Performance Optics LLC has a specialty in eyeglass lenses. Chris Newmarker

  • Theranos Sued by Major Investor

    The beleaguered Silicon Valley company lied to win over investors, according to a major funder. Theranos denies the accusation.  Qmed Staff

  • Alphatec Laying Off Dozens of Workers

    The spine device company’s chief financial officer has also resigned. Chris Newmarker Alphatec recently announced that it will cut its workforce by about a fifth amid a $20 million expense cutting plan. The company had 430 employees as of December 31, 2015, according to its most recent annual report. So the jobs cuts could affect more than 80 workers.

  • EpiPen Maker Settles With DOJ for $465 Million

    The company was accused of paying state Medicaid programs a generic rebate for brand-name product. Nancy Crotti

  • Vascular Solutions Hit With Another Class I Recall

    This time, the recall involves nearly 16,000 catheters.  Maureen Kingsley A potential defect in some of Vascular Solutions’s dual-access catheters may pose a risk of embolism in patients, the Maple Grove, MN–based company has announced.  Vascular Solutions initiated a recall of the Twin-Pass dual-access catheters on September 16; the company says FDA has designated the recall as Class I level.